entertainment -WSS

entertainment

author：entertainment 2025-10-02 10:11:56 Page View：486

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Breakthrough Alzheimer’s drugs are inaccessible in rural states
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

explore

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Companies helping big Covid

AdobePfizerandModernaaren’ttheonlyvaccinemoney-makers.MuchoftherevenueandprofitsfromCovid-19vaccines

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

FILE-U.SsoccerplayerMeganRapinoespeakstoreportersduringthe2023Women'sWorldCupmediadayfortheUnitedSta